Articles dans des revues avec comité de lecture (182)
106.
Metens, T., Ferraresi, K. F., Farchione, A., Moreno, C., Bali, M. A., & Matos Pinto De Almeida, C. (2014). Normal hepatic parenchyma visibility and ADC quantification on diffusion-weighted MRI at 3 T: influence of age, gender, and iron content. European radiology. doi:10.1007/s00330-014-3353-0107.
Trepo, E., Nahon, P., Bontempi, G., Valenti, L., Falleti, E., Nischalke, H. D., Hamza, S., Corradini, S. G., Burza, M. A., Guyot, E., Donati, B., Spengler, U., Hillon, P., Toniutto, P., Henrion, J., Franchimont, D., Devière, J., Mathurin, P., Moreno, C., Romeo, S., & Deltenre, P. (2014). Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data. Hepatology, 59(6), 2170-2177. doi:10.1002/hep.26767109.
Gustot, T., Felleiter, P., Pickkers, P., Sakr, Y., Rello, J., Velissaris, D., Pierrakos, C., Taccone, F., Sevcik, P., Moreno, C., Vincent, J. L., & the EPIC II Group of Investigators, (2014). Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study. Liver international. doi:10.1111/liv.12520110.
Gustot, T., Maillart, E., Bocci, M., Surin, R., Trepo, E., Degré, D., Lucidi, V., Taccone, F., Delforge, M.-L., Vincent, J. L., Donckier De Donceel, V., Jacobs, F., & Moreno, C. (2014). Invasive aspergillosis in patients with severe alcoholic hepatitis. Journal of hepatology, 60(2), 267-274. doi:10.1016/j.jhep.2013.09.011111.
Colombo, M., Iraqi, W., DeMasi, R., Hill, A., Lonjon-Domanec, I., Wedemeyer, H., Strasser, S., Moreno, C., Ferreira, P. A., Urbanek, P., Fernández, I., Abdurakhmanov, D., Streinu-Cercel, A., & Verheyen, A. (2014). Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program. Journal of hepatology, 61(5), 976-983. doi:10.1016/j.jhep.2014.06.005112.
Ferenci, P., Bernstein, D., Lalezari, J., Nyberg, A., Enayati, P., Green, S., Hassanein, T., Cohen, D., Luo, Y., Xie, W., King, M., Podsadecki, T., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Box, T. T., Younes, Z., Baruch, Y., Bhandari, B. R., Caruntu, F. A., Sepe, T., Chulanov, V., Janczewska, E., Rizzardini, G., Gervain, J., Planas, R., Moreno, C., & Reddy, K. R. (2014). ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV. The New England journal of medicine, 370(21), 1983-1992. doi:10.1056/NEJMoa1402338113.
Van Damme, P., Laleman, W., Starkel, P., van Vlierberghe, H., Vandijck, D., Hindman, S. S., Razavi, H., & Moreno, C. (2014). Hepatitis C epidemiology in Belgium. Acta gastro-enterologica Belgica (Ed. multilingue), 77(2), 277-279.114.
Vandijck, D., Moreno, C., Starkel, P., Van Damme, P., van Vlierberghe, H., Hindman, S. S., Razavi, H., & Laleman, W. (2014). Current and future health and economic impact of hepatitis C in Belgium. Acta gastro-enterologica Belgica (Ed. multilingue), 77(2), 285-290.115.
Starkel, P., Vandijck, D., Laleman, W., Van Damme, P., Moreno, C., Hindman, S. S., Razavi, H., & van Vlierberghe, H. (2014). The disease burden of hepatitis C in Belgium: Development of a realistic disease control strategy. Acta gastro-enterologica Belgica (Ed. multilingue), 77(2), 280-284.116.
Colombo, M., Fernández, I., Abdurakhmanov, D., Ferreira, P. A., Strasser, S. I., Urbanek, P., Moreno, C., Streinu-Cercel, A., Verheyen, A., Iraqi, W., Demasi, R., Hill, A., Läuffer, J. M., Lonjon-Domanec, I., & Wedemeyer, H. (2013). Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C. Gut. doi:10.1136/gutjnl-2013-305667